Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1983 1
1984 1
1989 3
1990 3
1991 3
1992 1
1993 3
1994 1
1995 5
1996 6
1997 5
1998 2
1999 5
2000 9
2001 8
2002 2
2003 14
2004 8
2005 8
2006 6
2007 9
2008 14
2009 11
2010 14
2011 17
2012 11
2013 14
2014 15
2015 16
2016 14
2017 15
2018 17
2019 15
2020 11
Text availability
Article attribute
Article type
Publication date

Search Results

258 results
Results by year
Filters applied: . Clear all
Page 1
PBC-transplantation and disease recurrence.
Nevens F. Nevens F. Best Pract Res Clin Gastroenterol. 2018 Jun-Aug;34-35:107-111. doi: 10.1016/j.bpg.2018.09.001. Epub 2018 Sep 11. Best Pract Res Clin Gastroenterol. 2018. PMID: 30343704 Review.
Recurrent PBC is reported in a range from 14% up to 42% after LT but in contrast to other autoimmune diseases graft loss due to recurrent disease is not a major issue. ...Observational studies suggest that long-term administration of UDCA following LT has a b
Recurrent PBC is reported in a range from 14% up to 42% after LT but in contrast to other autoimmune diseases graft loss due t
Liver transplantation in PBC and PSC: indications and disease recurrence.
Carbone M, Neuberger J. Carbone M, et al. Clin Res Hepatol Gastroenterol. 2011 Jun;35(6-7):446-54. doi: 10.1016/j.clinre.2011.02.007. Epub 2011 Apr 1. Clin Res Hepatol Gastroenterol. 2011. PMID: 21459072 Review.
The diagnosis of recurrent disease should be made on agreed criteria. The impact of recurrent disease on survival is unclear. Study of recurrent PBC and PSC may provide a better understanding of the mechanisms of these diseases in the native liver....
The diagnosis of recurrent disease should be made on agreed criteria. The impact of recurrent disease on survival is unclear. …
Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation.
Visseren T, Darwish Murad S. Visseren T, et al. Best Pract Res Clin Gastroenterol. 2017 Apr;31(2):187-198. doi: 10.1016/j.bpg.2017.04.004. Epub 2017 Apr 12. Best Pract Res Clin Gastroenterol. 2017. PMID: 28624107 Review.
Liver transplantation is a well-accepted treatment for decompensated chronic liver disease due to primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC) and auto-immune hepatitis (AIH). ...In this review we discuss the incidence, clinical presentation, cha …
Liver transplantation is a well-accepted treatment for decompensated chronic liver disease due to primary sclerosing cholangitis (PSC), prim …
Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival.
Montano-Loza AJ, Hansen BE, Corpechot C, Roccarina D, Thorburn D, Trivedi P, Hirschfield G, McDowell P, Poupon R, Dumortier J, Bosch A, Giostria E, Conti F, Parés A, Reig A, Floreani A, Russo FP, Goet JC, Harms MH, van Buuren H, Van den Ende N, Nevens F, Verhelst X, Donato MF, Malinverno F, Ebadi M, Mason AL; Global PBC Study Group. Montano-Loza AJ, et al. Gastroenterology. 2019 Jan;156(1):96-107.e1. doi: 10.1053/j.gastro.2018.10.001. Epub 2018 Oct 6. Gastroenterology. 2019. PMID: 30296431
BACKGROUND & AIMS: Primary biliary cholangitis (PBC) frequently recurs after liver transplantation. We evaluated risk factors associated with recurrence of PBC and its effects on patient and graft survival in a multicenter, international cohort (the Globa …
BACKGROUND & AIMS: Primary biliary cholangitis (PBC) frequently recurs after liver transplantation. We evaluated risk factors ass …
Systematic review: recurrent autoimmune liver diseases after liver transplantation.
Montano-Loza AJ, Bhanji RA, Wasilenko S, Mason AL. Montano-Loza AJ, et al. Aliment Pharmacol Ther. 2017 Feb;45(4):485-500. doi: 10.1111/apt.13894. Epub 2016 Dec 12. Aliment Pharmacol Ther. 2017. PMID: 27957759 Free article. Review.
Outcomes post LT are generally good but recurrent disease is frequently observed. AIMS: To describe the frequency and risk factors associated with recurrent AILD post-LT and provide recommendations to reduce the incidence of recurrence based on levels of evid …
Outcomes post LT are generally good but recurrent disease is frequently observed. AIMS: To describe the frequency and risk factors as …
Risk factors for metachronous contralateral breast cancer: A systematic review and meta-analysis.
Akdeniz D, Schmidt MK, Seynaeve CM, McCool D, Giardiello D, van den Broek AJ, Hauptmann M, Steyerberg EW, Hooning MJ. Akdeniz D, et al. Breast. 2019 Apr;44:1-14. doi: 10.1016/j.breast.2018.11.005. Epub 2018 Dec 6. Breast. 2019. PMID: 30580169
BACKGROUND: The risk of developing metachronous contralateral breast cancer (CBC) is a recurrent topic at the outpatient clinic. ...In population-based cohorts, PBC family history (RR = 1.8; 95%CI:1.2-2.6), body mass index (BMI) ≥30 kg/m(2) (RR = 1.5; 95%CI:1.3-1.9) …
BACKGROUND: The risk of developing metachronous contralateral breast cancer (CBC) is a recurrent topic at the outpatient clinic. ...I …
Autoimmune liver disease, autoimmunity and liver transplantation.
Carbone M, Neuberger JM. Carbone M, et al. J Hepatol. 2014 Jan;60(1):210-23. doi: 10.1016/j.jhep.2013.09.020. Epub 2013 Sep 29. J Hepatol. 2014. PMID: 24084655 Free article. Review.
Primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH) represent the three major autoimmune liver diseases (AILD). ...Cholangiocarcinoma, except under rigorous selection criteria, excludes LT because of the high risk of recu
Primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH) represent the three major autoim …
Results of Percutaneous Balloon Compression in Trigeminal Pain Syndromes.
Grewal SS, Kerezoudis P, Garcia O, Quinones-Hinojosa A, Reimer R, Wharen RE. Grewal SS, et al. World Neurosurg. 2018 Jun;114:e892-e899. doi: 10.1016/j.wneu.2018.03.111. Epub 2018 Mar 23. World Neurosurg. 2018. PMID: 29581020
OBJECTIVE: To investigate initial pain relief and subsequent recurrence after percutaneous balloon compression (PBC) and describe its association with the nature of trigeminal pain, previous procedures, or other clinical factors. ...CONCLUSIONS: Our study demonstrat …
OBJECTIVE: To investigate initial pain relief and subsequent recurrence after percutaneous balloon compression (PBC) and descr …
PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas.
Cimino-Mathews A, Thompson E, Taube JM, Ye X, Lu Y, Meeker A, Xu H, Sharma R, Lecksell K, Cornish TC, Cuka N, Argani P, Emens LA. Cimino-Mathews A, et al. Hum Pathol. 2016 Jan;47(1):52-63. doi: 10.1016/j.humpath.2015.09.003. Epub 2015 Sep 21. Hum Pathol. 2016. PMID: 26527522 Free PMC article.

Peripheral lymphoid aggregates were present in 100% of PD-L1(+) compared to 41% of PD-L1(-) PBC (P < .001). No patient with PD-L1(+) PBC developed distant recurrence, compared to 15% of patients with PD-L1(-) PBC. For the matched PBC and MBC

Peripheral lymphoid aggregates were present in 100% of PD-L1(+) compared to 41% of PD-L1(-) PBC (P < .001). No patient with PD-L1(

Clinical efficacy of combination of pertuzumab, trastuzumab, and docetaxel for treatment of patients with HER2-positive breast cancer.
Liu YC, Ma Y, An N, Sun P, Wang Y, Sun C. Liu YC, et al. Medicine (Baltimore). 2019 Sep;98(38):e17262. doi: 10.1097/MD.0000000000017262. Medicine (Baltimore). 2019. PMID: 31568001 Free PMC article.
RESULTS: This study will summarize up-to-date evidence of PTD for patients with HER2-PBC via overall survival, complete response, cancer-specific survival, recurrence-free survival, disease-free survival, quality of life, and toxicities. CONCLUSION: This study will …
RESULTS: This study will summarize up-to-date evidence of PTD for patients with HER2-PBC via overall survival, complete response, can …
258 results
Jump to page
Feedback